Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 2

Research Article

Acupoint Embedding of Polyglactin 910 Sutures in Patients with Chronic Pain due to Cervical Spondylotic Radiculopathy: A Multicenter, Randomized, Controlled Clinical Trial

Table 2

Primary outcome measures.

Outcome MeasureSAE
(n = 34)
MAPE
(n = 34)
DAPE
(n = 34)
Tukey’s comparison
MAPE vs. SAE DAPE vs. SAE DAPE vs. MAPE
Diff. (95% CI)PDiff. (95% CI)PDiff. (95% CI)P

Visual Analog Scale (VAS), Mean ± SD
Baseline6.1 ± 0.65.5 ± 1.05.4 ± 1.8−0.6 (−1.2 to 0.0)>.05−0.6 (−1.2 to 0.0)>.05−0.0 (−0.7 to 0.6)>.05
T 1w5.8 ± 0.94.2 ± 1.23.7 ± 1.4−1.5 (−2.2 to −0.9)<.001−2.1 (−2.7 to −1.4)<.001−0.5 (−1.2 to 0.1)>.05
T 2w6.2 ± 1.13.0 ± 1.02.5 ± 1.5−3.3 (−3.9 to −2.6)<.001−3.7 (−4.4 to −3.1)<.001−0.4 (−1.1 to 0.2)>.05
T 3w5.9 ± 0.82.5 ± 1.21.6 ± 0.7−3.4 (−4.0 to −2.7)<.001−4.2 (−4.9 to −3.6)<.001−0.9 (−1.5 to −0.3)<.01
F 4w5.8 ± 0.82.9 ± 1.12.4 ± 1.5−2.9 (−3.5 to −2.2)<.001−3.4 (−4.0 to −2.8)<.001−0.5 (−1.2 to 0.1)>.05
F 10w6.0 ± 0.92.2 ± 0.72.2 ± 0.5−3.8 (−4.4 to −3.2)<.001−3.8 (−4.4 to −3.2)<.0010.0 (−0.6 to 0.6)>.05
P(t)0.109<.001<.001NA

SAE, sham acupoint embedding group; MAPE, middle-layer (the semispinalis capitis muscle layer) PGLA embedding group; DAPE, deep-layer (the multifidus muscle layer) PGLA embedding group; CI, confidence interval; NA, not applicable. 1w, 1 week; 2w, 2 weeks; and 3w, 3 weeks; 4w, 4 weeks; 10w, 10 weeks; T, treatment; F, follow-up. P(t) refers to the p-values between different treatment time points.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.